These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6969348)

  • 1. Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients.
    Ekert H; Jurk IH; Waters KD; Tiedemann K
    Med Pediatr Oncol; 1980; 8(1):47-51. PubMed ID: 6969348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.
    Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L
    Infection; 1989; 17(2):65-9. PubMed ID: 2654019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.
    Starke ID; Donnelly P; Catovsky D; Darrell J; Johnson SA; Goldman JM; Galton DA
    Lancet; 1982 Jan; 1(8262):5-6. PubMed ID: 6119443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
    Malarme M; Meunier-Carpentier F; Klastersky J
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
    [No Abstract]   [Full Text] [Related]  

  • 5. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
    Henry SA
    Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
    Bow EJ; Rayner E; Scott BA; Louie TJ
    Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
    Wolff LJ
    Am J Pediatr Hematol Oncol; 1984; 6(3):267-76. PubMed ID: 6393790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Co-trimoxazole chemoprophylaxis in immunocompromised patients: analysis of the literature].
    Gava R; Carli M
    G Clin Med; 1989 Jan; 70(1):37-9, 42-6. PubMed ID: 2668092
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-trimoxazole in patients with haematological malignancies: a review of 10-years' clinical experience.
    De Pauw BE; Novakova IR; Ubachs E; Hoes A; Stalpers L; Verhagen C
    Curr Med Res Opin; 1988; 11(1):64-72. PubMed ID: 3260168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin.
    Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
    J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.
    Bow EJ; Louie TJ; Riben PD; McNaughton RD; Harding GK; Ronald AR
    Am J Med; 1984 Feb; 76(2):223-33. PubMed ID: 6364804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of co-trimoxazole- and gentamicin-resistant Klebsiella aerogenes bacteremia in neutropenic patients receiving oral co-trimoxazole prophylaxis.
    Leahy MF; Humble MW
    Aust N Z J Med; 1983 Dec; 13(6):636-8. PubMed ID: 6372773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer.
    Braine HG; Stuart RK; Saral R; Lietman PS
    Rev Infect Dis; 1982; 4(2):586-92. PubMed ID: 7051248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    Infection; 1983; 11(3):167-9. PubMed ID: 6604030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
    Zinner SH
    Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-trimoxazole from the therapeutic viewpoint.
    Lode H
    Infection; 1987; 15 Suppl 5():S222-6. PubMed ID: 3325432
    [No Abstract]   [Full Text] [Related]  

  • 19. Current guidelines on the use of antibacterial drugs in patients with malignancies.
    Mayer KH; DeTorres OH
    Drugs; 1985 Mar; 29(3):262-79. PubMed ID: 3886354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
    Marty M; Gisselbrecht C; Samson-Lepors MJ
    Nouv Presse Med; 1979 Oct; 8(42):3465-8. PubMed ID: 537897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.